Top Story

S-stamp marking technique helps prevent inverted graft implantation in DMEK

Ocular Surgery News U.S. Edition, May 10, 2016

Read the Perspective from Albert S. Jun, MD, PhD

A novel S-stamp marking method eliminated upside-down graft implantation in Descemet’s membrane endothelial keratoplasty, according to a study.

The technique may help surgeons perfect the DMEK technique and avoid complications, according to Peter B. Veldman, MD, the corresponding author.

By the Numbers

Recognizing and addressing professional burnout

Ocular Surgery News U.S. Edition, May 10, 2016
John B. Pinto
“I have a theory that burnout is about resentment. And you beat it by knowing what it is you’re giving up that makes you resentful.”– Marissa…
Complications Consult

Minimally invasive micro sclerostomy may be alternative to trabeculectomy

Ocular Surgery News U.S. Edition, May 10, 2016
Dhivya Ashok Kumar, MD, FICO; Amar Agarwal, MS, FRCS, FRCOphth
The gold standard surgery for decreasing IOP in patients with glaucoma is trabeculectomy. However, it has possible disadvantages, such as failure secondary to…
Cover Story

Sustained-release drug delivery products edge closer to fruition

Ocular Surgery News U.S. Edition, May 10, 2016
Eye drops and injections, when needed day after day or month after month, can take a toll. Patient compliance with therapy becomes a problem. Treatment becomes…

Keys for a successful practice include implementing, establishing brand recognition

Ocular Surgery News U.S. Edition, May 10, 2016
Price M. Kloess, MD
Practicing ophthalmology during this era of comprehensive health care reform and constantly evolving technology requires a level of diligence never before required of…
More News Headlines »
Original Article

Influence of Near-Segment Positioning in a Rotationally Asymmetric Multifocal Intraocular Lens

Journal of Refractive Surgery, April 2016, Volume 32 Issue 4
To compare visual performance and higher order aberrations (HOAs) based on the position of the near segment in eyes…
More »

Wet Macular Degeneration: A Review of Pivotal Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Highlights from ARVO

Highlights from ARVO

Meeting News Coverage

VIDEO: Luminate meets primary endpoint in phase 2 study for vitreomacular traction

May 2, 2016
More »